Salou Diallo1, Stephen A Roberts2, Sabine Gies3, Toussaint Rouamba4, Dorine W Swinkels5, Anneke J Geurts-Moespot6, Sayouba Ouedraogo7, Georges Anicet Ouedraogo8, Halidou Tinto9, Bernard J Brabin10. 1. Clinical Research Unit of Nanoro (URCN/IRSS), Nanoro, Burkina Faso. Electronic address: saloudiallo89@yahoo.fr. 2. Centre for Biostatistics, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre (MAHSC), Oxford Road, University of Manchester, Manchester, M139PL, UK. Electronic address: steve.roberts@manchester.ac.uk. 3. Department of Biomedical Sciences, Prince Leopold Institute of Tropical Medicine, Nationalestraat 155, 2000, Antwerp, Belgium; Medical Mission Institute, Würzburg, Germany. Electronic address: sabine.gies@medmissio.de. 4. Clinical Research Unit of Nanoro (URCN/IRSS), Nanoro, Burkina Faso. Electronic address: rouambatoussaint@gmail.com. 5. Department of Laboratory Medicine (TLM 830), Radboud University Nijmegen Medical Center, PO Box 9101, 6500 HB, Nijmegen, the Netherlands; Hepcidinanalysis.com, Geert Grooteplein 10 (830), 6525 GA, Nijmegen, the Netherlands. Electronic address: Dorine.Swinkels@radboudumc.nl. 6. Hepcidinanalysis.com, Geert Grooteplein 10 (830), 6525 GA, Nijmegen, the Netherlands. Electronic address: Anneke.Geurts-Moespot@radboudumc.nl. 7. Clinical Research Unit of Nanoro (URCN/IRSS), Nanoro, Burkina Faso. Electronic address: dm_osayouba@yahoo.fr. 8. Université polytechnique de Bobo Dioulasso, PO Box 1091, Burkina Faso. Electronic address: oga@fasonet.bf. 9. Clinical Research Unit of Nanoro (URCN/IRSS), Nanoro, Burkina Faso. Electronic address: halidoutinto@gmail.com. 10. Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L35QA, England, UK; Institute of Infection and Global Health, University of Liverpool, UK; Global Child Health Group, Academic Medical Centre, University of Amsterdam, the Netherlands. Electronic address: b.j.brabin@liverpool.ac.uk.
Abstract
BACKGROUND & AIMS: Low iron stores may protect from malaria infection, therefore improving iron stores in early pregnancy in line with current recommendations could increase malaria susceptibility. To test this hypothesis we compared iron biomarkers and red cell indices in nulliparae and primigravidae who participated in a randomized controlled trial of long-term weekly iron supplementation. METHODS: Cross-sectional and longitudinal data analysis from a randomized controlled trial of long-term weekly iron supplementation in rural Burkina Faso. Malaria parasitaemia was monitored and biomarkers and red cell indices measured at study end-points: plasma ferritin, transferrin receptor (sTfR), zinc protoporphyrin, hepcidin, sTfR/log10 ferritin ratio, body iron, haemoglobin, red cell distribution width; mean corpuscular haemoglobin concentration/volume, and C-reactive protein. Correlation coefficients between biomarkers and red cell indices were determined. A regression correction approach based on ferritin was used to estimate iron body stores, allowing for inflammation. Body iron differences were compared between nulliparae and primigravidae, and the association determined of iron biomarkers and body iron stores with malaria. RESULTS: Iron and haematological indices of 972 nulliparae (mean age 16.5 years) and 314 primigravidae (median gestation 18 weeks) were available. Malaria prevalence was 54.0% in primigravidae and 41.8% in nulliparae (relative risk 1.28, 95% CI 1.13-1.45, P < 0.001), anaemia prevalence 69.7% and 43.4% (P < 0.001), and iron deficient erythropoiesis (low body iron) 8.0% and 11.7% (P = 0.088) respectively. Unlike other biomarkers the sTfR/log10 ferritin ratio showed no correlation with inflammation as measured by CRP. Most biomarkers indicated reduced iron deficiency in early pregnancy, with the exception of haemoglobin. Body iron increased by 0.6-1.2 mg/kg in early gestation, did not differ by malaria status in nulliparae, but was higher in primigravidae with malaria (6.5 mg/kg versus 5.0 mg/kg; relative risk 1.53, 95% CI 0.67-2.38, P < 0.001). CONCLUSION: In primigravidae, early pregnancy haemoglobin was not a good indicator of requirement for iron supplementation, which could be detrimental given the association of better iron status with increased malaria infection. TRIAL REGISTRATION: clinicaltrials.gov:NCT01210040. Until placed in a public repository, data relating to the current study can be requested from the corresponding author and will be made available following an end user data agreement and sponsor approval.
RCT Entities:
BACKGROUND & AIMS: Low iron stores may protect from malaria infection, therefore improving iron stores in early pregnancy in line with current recommendations could increase malaria susceptibility. To test this hypothesis we compared iron biomarkers and red cell indices in nulliparae and primigravidae who participated in a randomized controlled trial of long-term weekly iron supplementation. METHODS: Cross-sectional and longitudinal data analysis from a randomized controlled trial of long-term weekly iron supplementation in rural Burkina Faso. Malaria parasitaemia was monitored and biomarkers and red cell indices measured at study end-points: plasma ferritin, transferrin receptor (sTfR), zinc protoporphyrin, hepcidin, sTfR/log10 ferritin ratio, body iron, haemoglobin, red cell distribution width; mean corpuscular haemoglobin concentration/volume, and C-reactive protein. Correlation coefficients between biomarkers and red cell indices were determined. A regression correction approach based on ferritin was used to estimate iron body stores, allowing for inflammation. Body iron differences were compared between nulliparae and primigravidae, and the association determined of iron biomarkers and body iron stores with malaria. RESULTS:Iron and haematological indices of 972 nulliparae (mean age 16.5 years) and 314 primigravidae (median gestation 18 weeks) were available. Malaria prevalence was 54.0% in primigravidae and 41.8% in nulliparae (relative risk 1.28, 95% CI 1.13-1.45, P < 0.001), anaemia prevalence 69.7% and 43.4% (P < 0.001), and iron deficient erythropoiesis (low body iron) 8.0% and 11.7% (P = 0.088) respectively. Unlike other biomarkers the sTfR/log10 ferritin ratio showed no correlation with inflammation as measured by CRP. Most biomarkers indicated reduced iron deficiency in early pregnancy, with the exception of haemoglobin. Body iron increased by 0.6-1.2 mg/kg in early gestation, did not differ by malaria status in nulliparae, but was higher in primigravidae with malaria (6.5 mg/kg versus 5.0 mg/kg; relative risk 1.53, 95% CI 0.67-2.38, P < 0.001). CONCLUSION: In primigravidae, early pregnancy haemoglobin was not a good indicator of requirement for iron supplementation, which could be detrimental given the association of better iron status with increased malaria infection. TRIAL REGISTRATION: clinicaltrials.gov:NCT01210040. Until placed in a public repository, data relating to the current study can be requested from the corresponding author and will be made available following an end user data agreement and sponsor approval.
Authors: Smaïla Ouédraogo; Ghislain K Koura; Manfred M K Accrombessi; Florence Bodeau-Livinec; Achille Massougbodji; Michel Cot Journal: Am J Trop Med Hyg Date: 2012-07-23 Impact factor: 2.345
Authors: W K Simmons; J D Cook; K C Bingham; M Thomas; J Jackson; M Jackson; N Ahluwalia; S G Kahn; A W Patterson Journal: Am J Clin Nutr Date: 1993-11 Impact factor: 7.045
Authors: Caitlin T Howard; Uri S McKakpo; Isabella A Quakyi; Kwabena M Bosompem; Ebenezer A Addison; Kai Sun; David Sullivan; Richard D Semba Journal: Am J Trop Med Hyg Date: 2007-10 Impact factor: 2.345
Authors: Martin N Mwangi; Sumi Maskey; Pauline E A Andang o; Noel K Shinali; Johanna M Roth; Laura Trijsburg; Alice M Mwangi; Han Zuilhof; Barend van Lagen; Huub Fj Savelkoul; Ayşe Y Demir; Hans Verhoef Journal: BMC Med Date: 2014-11-26 Impact factor: 8.775
Authors: Mary Dawn Koenig; Lisa Tussing-Humphreys; Jessica Day; Brooke Cadwell; Elizabeta Nemeth Journal: Nutrients Date: 2014-08-04 Impact factor: 5.717
Authors: Holger W Unger; Andie Bleicher; Maria Ome-Kaius; Elizabeth H Aitken; Stephen J Rogerson Journal: Malar J Date: 2022-05-26 Impact factor: 3.469
Authors: Mary Amoakoh-Coleman; Daniel K Arhinful; Kerstin Klipstein-Grobusch; Evelyn K Ansah; Kwadwo A Koram Journal: Malar J Date: 2020-06-24 Impact factor: 2.979
Authors: Bernard Brabin; Sabine Gies; Stephen A Roberts; Salou Diallo; Olga M Lompo; Adama Kazienga; Loretta Brabin; Sayouba Ouedraogo; Halidou Tinto Journal: Malar J Date: 2019-05-06 Impact factor: 2.979
Authors: S A Roberts; L Brabin; S Diallo; S Gies; A Nelson; C Stewart; D W Swinkels; A J Geurts-Moespot; A Kazienga; S Ouedraogo; U D'Alessandro; H Tinto; B J Brabin Journal: Eur J Clin Nutr Date: 2019-06-05 Impact factor: 4.016
Authors: Sabine Gies; Stephen A Roberts; Salou Diallo; Olga M Lompo; Halidou Tinto; Bernard J Brabin Journal: Matern Child Nutr Date: 2020-11-25 Impact factor: 3.092